antiretroviral intensification
Showing 1 - 25 of 2,154
HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))
Completed
- HIV Infections
- Placebo for maraviroc (MVC)
- +3 more
-
Los Angeles, California
- +29 more
Apr 20, 2022
HIV Trial in Thailand (Nevirapine, zidovudine, lamivudine)
Completed
- HIV Infections
- Nevirapine, zidovudine, lamivudine
-
Chanthaburi, Chantaburi, Thailand
- +35 more
Oct 20, 2021
HIV Infection Trial in Bethesda, Pittsburgh (Pegylated Interferon Alpha 2b (PEGINTRON))
Completed
- HIV Infection
- Pegylated Interferon Alpha 2b (PEGINTRON)
-
Bethesda, Maryland
- +1 more
Apr 1, 2019
HIV-1 Infection Trial in Montpellier (HIV DNA)
Completed
- HIV-1 Infection
- HIV DNA
-
Montpellier, FranceUniversity hospital Montpellier
Jul 5, 2021
HIV Trial in United States (Raltegravir (MK-0518), Placebo)
Completed
- HIV Infections
- Raltegravir (MK-0518)
- Placebo
-
Birmingham, Alabama
- +19 more
Nov 2, 2021
HIV Trial in United States (Indinavir sulfate, Lamivudine/Zidovudine, Hydroxyurea)
Completed
- HIV Infections
- Indinavir sulfate
- +6 more
-
Birmingham, Alabama
- +33 more
Oct 27, 2021
HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)
Completed
- HIV
- Acute HIV Infection
- Dolutegravir 50 mg
- +2 more
-
Chapel Hill, North Carolina
- +1 more
Oct 22, 2021
HIV/AIDS Trial in Elandsdoorn (Intensified monitoring, Standard of care monitoring)
Completed
- HIV/AIDS
- Intensified monitoring
- Standard of care monitoring
-
Elandsdoorn, Limpopo, South AfricaNdlovu Medical Centre
May 10, 2022
Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria
Recruiting
- Spontaneous Urticaria, Chronic
-
Lille, FranceHop Claude Huriez Chu Lille
Jan 25, 2023
COVID-19 Trial in Minneapolis (abatacept infusion, Placebo group)
Not yet recruiting
- COVID-19
- abatacept infusion
- Placebo group
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 18, 2023
COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))
Completed
- COVID-19
- Recombinant Novel Coronavirus vaccine (CHO Cells)
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Jun 6, 2023
Therapeutic Intervention on Quality of Life in Ulcerative
Not yet recruiting
- IBD-Inflammatory Bowel Disease
- UC - Ulcerative Colitis
-
La Laguna, Santa Cruz De Tenerife, SpainHospital Universitario de Canarias
Mar 9, 2022
High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)
Not yet recruiting
- High-Risk de Novo Multiple Myeloma
- Daratumumab
- +5 more
-
Badalona, Spain
- +9 more
Apr 27, 2023
HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou
Recruiting
- HIV Infection
- Combined Antiretroviral Therapy
-
Hangzhou, Zhejiang, ChinaZhikai Wan
Aug 30, 2023
ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)
Not yet recruiting
- ASCVD
- Coronary Artery Calcification
- Notification of patients and clinicians
- (no location specified)
May 5, 2023
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +9 more
-
Birmingham, Alabama
- +52 more
Oct 27, 2021
Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Glucose, High Blood
-
Cheonju, Chungcheongbuk-do, Korea, Republic ofChungbuk National University Hospital
Jul 19, 2022
Pulmonary Arterial Hypertension Trial (Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Selexipag
- +3 more
- (no location specified)
Apr 11, 2023
Prostate Adenocarcinoma Trial in Madrid (Prostate SBRT (stereotactic body radiation therapy) with focal boost)
Not yet recruiting
- Prostate Adenocarcinoma
- Prostate SBRT (stereotactic body radiation therapy) with focal boost
-
Madrid, SpainLa Princesa University Hospital, Health Research Institute, Madr
Jun 16, 2023
Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)
Not yet recruiting
- Hiv
- Self-guided health education
- +2 more
-
Bronx, New York
- +5 more
Apr 17, 2023